 | • レポートコード：MRC2-11QY02563 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗感染症薬のグローバル市場について調査・分析したレポートです。種類別（抗菌薬、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗感染症薬の競争状況、市場シェア ・世界の抗感染症薬市場：種類別市場規模 2015年-2020年（抗菌薬、抗真菌薬、抗ウイルス薬） ・世界の抗感染症薬市場：種類別市場規模予測 2021年-2026年（抗菌薬、抗真菌薬、抗ウイルス薬） ・世界の抗感染症薬市場：用途別市場規模 2015年-2020年（病院用、診療所用、家庭用、その他） ・世界の抗感染症薬市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、家庭用、その他） ・北米の抗感染症薬市場分析：米国、カナダ ・ヨーロッパの抗感染症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗感染症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗感染症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗感染症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc.、Abbott Laboratories、Gilead Sciences, Inc.、Bristol-Myers Squibb Co.、Merck & Co., Inc.、Bayer Healthcare AG、AstraZeneca Plc.、Boehringer Ingelheim、Novartis AG、Astellas Pharma, Inc.、GlaxoSmithKline Plc.、Alcon Pharmaceuticals Ltd.、Sanofi-Aventis S.A.、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.
Market Analysis and Insights: Global Anti-infective Agents Market
The global Anti-infective Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-infective Agents Scope and Market Size
Anti-infective Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-infective Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-infective Agents market is segmented into
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Segment by Application, the Anti-infective Agents market is segmented into
Hospital Use
Clinic Use
Household
Other
Regional and Country-level Analysis
The Anti-infective Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-infective Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-infective Agents Market Share Analysis
Anti-infective Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-infective Agents business, the date to enter into the Anti-infective Agents market, Anti-infective Agents product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson
1 Study Coverage
1.1 Anti-infective Agents Product Introduction
1.2 Market Segments
1.3 Key Anti-infective Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-infective Agents Market Size Growth Rate by Type
1.4.2 Antibacterial Drugs
1.4.3 Antifungal Drugs
1.4.4 Antiviral Drugs
1.5 Market by Application
1.5.1 Global Anti-infective Agents Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-infective Agents Market Size, Estimates and Forecasts
2.1.1 Global Anti-infective Agents Revenue 2015-2026
2.1.2 Global Anti-infective Agents Sales 2015-2026
2.2 Global Anti-infective Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-infective Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-infective Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-infective Agents Competitor Landscape by Players
3.1 Anti-infective Agents Sales by Manufacturers
3.1.1 Anti-infective Agents Sales by Manufacturers (2015-2020)
3.1.2 Anti-infective Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-infective Agents Revenue by Manufacturers
3.2.1 Anti-infective Agents Revenue by Manufacturers (2015-2020)
3.2.2 Anti-infective Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-infective Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-infective Agents Revenue in 2019
3.2.5 Global Anti-infective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-infective Agents Price by Manufacturers
3.4 Anti-infective Agents Manufacturing Base Distribution, Product Types
3.4.1 Anti-infective Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-infective Agents Product Type
3.4.3 Date of International Manufacturers Enter into Anti-infective Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-infective Agents Market Size by Type (2015-2020)
4.1.1 Global Anti-infective Agents Sales by Type (2015-2020)
4.1.2 Global Anti-infective Agents Revenue by Type (2015-2020)
4.1.3 Anti-infective Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-infective Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-infective Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-infective Agents Revenue Forecast by Type (2021-2026)
4.2.3 Anti-infective Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-infective Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-infective Agents Market Size by Application (2015-2020)
5.1.1 Global Anti-infective Agents Sales by Application (2015-2020)
5.1.2 Global Anti-infective Agents Revenue by Application (2015-2020)
5.1.3 Anti-infective Agents Price by Application (2015-2020)
5.2 Anti-infective Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-infective Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-infective Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-infective Agents Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-infective Agents by Country
6.1.1 North America Anti-infective Agents Sales by Country
6.1.2 North America Anti-infective Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-infective Agents Market Facts & Figures by Type
6.3 North America Anti-infective Agents Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-infective Agents by Country
7.1.1 Europe Anti-infective Agents Sales by Country
7.1.2 Europe Anti-infective Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-infective Agents Market Facts & Figures by Type
7.3 Europe Anti-infective Agents Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-infective Agents by Region
8.1.1 Asia Pacific Anti-infective Agents Sales by Region
8.1.2 Asia Pacific Anti-infective Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-infective Agents Market Facts & Figures by Type
8.3 Asia Pacific Anti-infective Agents Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-infective Agents by Country
9.1.1 Latin America Anti-infective Agents Sales by Country
9.1.2 Latin America Anti-infective Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-infective Agents Market Facts & Figures by Type
9.3 Central & South America Anti-infective Agents Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-infective Agents by Country
10.1.1 Middle East and Africa Anti-infective Agents Sales by Country
10.1.2 Middle East and Africa Anti-infective Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-infective Agents Market Facts & Figures by Type
10.3 Middle East and Africa Anti-infective Agents Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description and Business Overview
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Anti-infective Agents Products Offered
11.1.5 Pfizer Inc. Related Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Description and Business Overview
11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Anti-infective Agents Products Offered
11.2.5 Abbott Laboratories Related Developments
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Corporation Information
11.3.2 Gilead Sciences, Inc. Description and Business Overview
11.3.3 Gilead Sciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Gilead Sciences, Inc. Anti-infective Agents Products Offered
11.3.5 Gilead Sciences, Inc. Related Developments
11.4 Bristol-Myers Squibb Co.
11.4.1 Bristol-Myers Squibb Co. Corporation Information
11.4.2 Bristol-Myers Squibb Co. Description and Business Overview
11.4.3 Bristol-Myers Squibb Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Co. Anti-infective Agents Products Offered
11.4.5 Bristol-Myers Squibb Co. Related Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Corporation Information
11.5.2 Merck & Co., Inc. Description and Business Overview
11.5.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck & Co., Inc. Anti-infective Agents Products Offered
11.5.5 Merck & Co., Inc. Related Developments
11.6 Bayer Healthcare AG
11.6.1 Bayer Healthcare AG Corporation Information
11.6.2 Bayer Healthcare AG Description and Business Overview
11.6.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Healthcare AG Anti-infective Agents Products Offered
11.6.5 Bayer Healthcare AG Related Developments
11.7 AstraZeneca Plc.
11.7.1 AstraZeneca Plc. Corporation Information
11.7.2 AstraZeneca Plc. Description and Business Overview
11.7.3 AstraZeneca Plc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AstraZeneca Plc. Anti-infective Agents Products Offered
11.7.5 AstraZeneca Plc. Related Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Description and Business Overview
11.8.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Boehringer Ingelheim Anti-infective Agents Products Offered
11.8.5 Boehringer Ingelheim Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Anti-infective Agents Products Offered
11.9.5 Novartis AG Related Developments
11.10 Astellas Pharma, Inc.
11.10.1 Astellas Pharma, Inc. Corporation Information
11.10.2 Astellas Pharma, Inc. Description and Business Overview
11.10.3 Astellas Pharma, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Astellas Pharma, Inc. Anti-infective Agents Products Offered
11.10.5 Astellas Pharma, Inc. Related Developments
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description and Business Overview
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Anti-infective Agents Products Offered
11.1.5 Pfizer Inc. Related Developments
11.12 Alcon Pharmaceuticals Ltd.
11.12.1 Alcon Pharmaceuticals Ltd. Corporation Information
11.12.2 Alcon Pharmaceuticals Ltd. Description and Business Overview
11.12.3 Alcon Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Alcon Pharmaceuticals Ltd. Products Offered
11.12.5 Alcon Pharmaceuticals Ltd. Related Developments
11.13 Sanofi-Aventis S.A.
11.13.1 Sanofi-Aventis S.A. Corporation Information
11.13.2 Sanofi-Aventis S.A. Description and Business Overview
11.13.3 Sanofi-Aventis S.A. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanofi-Aventis S.A. Products Offered
11.13.5 Sanofi-Aventis S.A. Related Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Corporation Information
11.14.2 Johnson & Johnson Description and Business Overview
11.14.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Johnson & Johnson Products Offered
11.14.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-infective Agents Market Estimates and Projections by Region
12.1.1 Global Anti-infective Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-infective Agents Revenue Forecast by Regions 2021-2026
12.2 North America Anti-infective Agents Market Size Forecast (2021-2026)
12.2.1 North America: Anti-infective Agents Sales Forecast (2021-2026)
12.2.2 North America: Anti-infective Agents Revenue Forecast (2021-2026)
12.2.3 North America: Anti-infective Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-infective Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-infective Agents Sales Forecast (2021-2026)
12.3.2 Europe: Anti-infective Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-infective Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-infective Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-infective Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-infective Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-infective Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-infective Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-infective Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-infective Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-infective Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-infective Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-infective Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-infective Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-infective Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-infective Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-infective Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-infective Agents Market Segments
Table 2. Ranking of Global Top Anti-infective Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-infective Agents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antibacterial Drugs
Table 5. Major Manufacturers of Antifungal Drugs
Table 6. Major Manufacturers of Antiviral Drugs
Table 7. Global Anti-infective Agents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-infective Agents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-infective Agents Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-infective Agents Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-infective Agents Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-infective Agents Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Anti-infective Agents Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-infective Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-infective Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-infective Agents as of 2019)
Table 16. Anti-infective Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-infective Agents Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-infective Agents Price (2015-2020) (USD/Unit)
Table 19. Anti-infective Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-infective Agents Product Type
Table 21. Date of International Manufacturers Enter into Anti-infective Agents Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 24. Global Anti-infective Agents Sales Share by Type (2015-2020)
Table 25. Global Anti-infective Agents Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-infective Agents Revenue Share by Type (2015-2020)
Table 27. Anti-infective Agents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 29. Global Anti-infective Agents Sales Share by Application (2015-2020)
Table 30. North America Anti-infective Agents Sales by Country (2015-2020) (K Units)
Table 31. North America Anti-infective Agents Sales Market Share by Country (2015-2020)
Table 32. North America Anti-infective Agents Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-infective Agents Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 35. North America Anti-infective Agents Sales Market Share by Type (2015-2020)
Table 36. North America Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 37. North America Anti-infective Agents Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-infective Agents Sales by Country (2015-2020) (K Units)
Table 39. Europe Anti-infective Agents Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-infective Agents Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-infective Agents Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 43. Europe Anti-infective Agents Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 45. Europe Anti-infective Agents Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-infective Agents Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Anti-infective Agents Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-infective Agents Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-infective Agents Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Anti-infective Agents Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Anti-infective Agents Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-infective Agents Sales by Country (2015-2020) (K Units)
Table 55. Latin America Anti-infective Agents Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-infective Agents Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-infective Agents Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 59. Latin America Anti-infective Agents Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 61. Latin America Anti-infective Agents Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-infective Agents Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Anti-infective Agents Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-infective Agents Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-infective Agents Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-infective Agents Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Anti-infective Agents Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-infective Agents Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-infective Agents Sales Market Share by Application (2015-2020)
Table 70. Pfizer Inc. Corporation Information
Table 71. Pfizer Inc. Description and Major Businesses
Table 72. Pfizer Inc. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Inc. Product
Table 74. Pfizer Inc. Recent Development
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Major Businesses
Table 77. Abbott Laboratories Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Abbott Laboratories Product
Table 79. Abbott Laboratories Recent Development
Table 80. Gilead Sciences, Inc. Corporation Information
Table 81. Gilead Sciences, Inc. Description and Major Businesses
Table 82. Gilead Sciences, Inc. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Gilead Sciences, Inc. Product
Table 84. Gilead Sciences, Inc. Recent Development
Table 85. Bristol-Myers Squibb Co. Corporation Information
Table 86. Bristol-Myers Squibb Co. Description and Major Businesses
Table 87. Bristol-Myers Squibb Co. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bristol-Myers Squibb Co. Product
Table 89. Bristol-Myers Squibb Co. Recent Development
Table 90. Merck & Co., Inc. Corporation Information
Table 91. Merck & Co., Inc. Description and Major Businesses
Table 92. Merck & Co., Inc. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck & Co., Inc. Product
Table 94. Merck & Co., Inc. Recent Development
Table 95. Bayer Healthcare AG Corporation Information
Table 96. Bayer Healthcare AG Description and Major Businesses
Table 97. Bayer Healthcare AG Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bayer Healthcare AG Product
Table 99. Bayer Healthcare AG Recent Development
Table 100. AstraZeneca Plc. Corporation Information
Table 101. AstraZeneca Plc. Description and Major Businesses
Table 102. AstraZeneca Plc. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AstraZeneca Plc. Product
Table 104. AstraZeneca Plc. Recent Development
Table 105. Boehringer Ingelheim Corporation Information
Table 106. Boehringer Ingelheim Description and Major Businesses
Table 107. Boehringer Ingelheim Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Boehringer Ingelheim Product
Table 109. Boehringer Ingelheim Recent Development
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Major Businesses
Table 112. Novartis AG Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Novartis AG Product
Table 114. Novartis AG Recent Development
Table 115. Astellas Pharma, Inc. Corporation Information
Table 116. Astellas Pharma, Inc. Description and Major Businesses
Table 117. Astellas Pharma, Inc. Anti-infective Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Astellas Pharma, Inc. Product
Table 119. Astellas Pharma, Inc. Recent Development
Table 120. GlaxoSmithKline Plc. Corporation Information
Table 121. GlaxoSmithKline Plc. Description and Major Businesses
Table 122. GlaxoSmithKline Plc. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. GlaxoSmithKline Plc. Product
Table 124. GlaxoSmithKline Plc. Recent Development
Table 125. Alcon Pharmaceuticals Ltd. Corporation Information
Table 126. Alcon Pharmaceuticals Ltd. Description and Major Businesses
Table 127. Alcon Pharmaceuticals Ltd. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Alcon Pharmaceuticals Ltd. Product
Table 129. Alcon Pharmaceuticals Ltd. Recent Development
Table 130. Sanofi-Aventis S.A. Corporation Information
Table 131. Sanofi-Aventis S.A. Description and Major Businesses
Table 132. Sanofi-Aventis S.A. Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sanofi-Aventis S.A. Product
Table 134. Sanofi-Aventis S.A. Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Major Businesses
Table 137. Johnson & Johnson Anti-infective Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Johnson & Johnson Product
Table 139. Johnson & Johnson Recent Development
Table 140. Global Anti-infective Agents Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Anti-infective Agents Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Anti-infective Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Anti-infective Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Anti-infective Agents Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Anti-infective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Anti-infective Agents Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Anti-infective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Anti-infective Agents Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Anti-infective Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Anti-infective Agents Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Anti-infective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Anti-infective Agents Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Anti-infective Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Anti-infective Agents Players
Table 158. Anti-infective Agents Customers List
Table 159. Anti-infective Agents Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-infective Agents Product Picture
Figure 2. Global Anti-infective Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Antibacterial Drugs Product Picture
Figure 4. Antifungal Drugs Product Picture
Figure 5. Antiviral Drugs Product Picture
Figure 6. Global Anti-infective Agents Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Use
Figure 8. Clinic Use
Figure 9. Household
Figure 10. Other
Figure 11. Anti-infective Agents Report Years Considered
Figure 12. Global Anti-infective Agents Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-infective Agents Sales 2015-2026 (K Units)
Figure 14. Global Anti-infective Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti-infective Agents Sales Market Share by Region (2015-2020)
Figure 16. Global Anti-infective Agents Sales Market Share by Region in 2019
Figure 17. Global Anti-infective Agents Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti-infective Agents Revenue Market Share by Region in 2019
Figure 19. Global Anti-infective Agents Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-infective Agents Revenue in 2019
Figure 21. Anti-infective Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-infective Agents Sales Market Share by Type (2015-2020)
Figure 23. Global Anti-infective Agents Sales Market Share by Type in 2019
Figure 24. Global Anti-infective Agents Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti-infective Agents Revenue Market Share by Type in 2019
Figure 26. Global Anti-infective Agents Market Share by Price Range (2015-2020)
Figure 27. Global Anti-infective Agents Sales Market Share by Application (2015-2020)
Figure 28. Global Anti-infective Agents Sales Market Share by Application in 2019
Figure 29. Global Anti-infective Agents Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti-infective Agents Revenue Market Share by Application in 2019
Figure 31. North America Anti-infective Agents Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Anti-infective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Anti-infective Agents Sales Market Share by Country in 2019
Figure 34. North America Anti-infective Agents Revenue Market Share by Country in 2019
Figure 35. U.S. Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Anti-infective Agents Market Share by Type in 2019
Figure 40. North America Anti-infective Agents Market Share by Application in 2019
Figure 41. Europe Anti-infective Agents Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Anti-infective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Anti-infective Agents Sales Market Share by Country in 2019
Figure 44. Europe Anti-infective Agents Revenue Market Share by Country in 2019
Figure 45. Germany Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Anti-infective Agents Market Share by Type in 2019
Figure 56. Europe Anti-infective Agents Market Share by Application in 2019
Figure 57. Asia Pacific Anti-infective Agents Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Anti-infective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Anti-infective Agents Sales Market Share by Region in 2019
Figure 60. Asia Pacific Anti-infective Agents Revenue Market Share by Region in 2019
Figure 61. China Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Anti-infective Agents Market Share by Type in 2019
Figure 84. Asia Pacific Anti-infective Agents Market Share by Application in 2019
Figure 85. Latin America Anti-infective Agents Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Anti-infective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Anti-infective Agents Sales Market Share by Country in 2019
Figure 88. Latin America Anti-infective Agents Revenue Market Share by Country in 2019
Figure 89. Mexico Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Anti-infective Agents Market Share by Type in 2019
Figure 96. Latin America Anti-infective Agents Market Share by Application in 2019
Figure 97. Middle East and Africa Anti-infective Agents Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Anti-infective Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti-infective Agents Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti-infective Agents Revenue Market Share by Country in 2019
Figure 101. Turkey Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti-infective Agents Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Anti-infective Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Anti-infective Agents Market Share by Type in 2019
Figure 108. Middle East and Africa Anti-infective Agents Market Share by Application in 2019
Figure 109. North America Anti-infective Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Anti-infective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Anti-infective Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Anti-infective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Anti-infective Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Anti-infective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Anti-infective Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Anti-infective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Anti-infective Agents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Anti-infective Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
固結防止剤の世界市場（～2026年） Anti-caking agents are utilized to prevent the formation of lumps, mostly in finely powdered substances. Anti-caking agents are soluble in alcohol, water and other organic solvents. They either absorb excess moisture or create a water-repellent coating on the powdered particles. Asia Pacific is expe…- 昆虫成長調節剤の世界市場（～2026年） Market Analysis and Insights: Global Anti-juvenile Hormone Agents Market The global Anti-juvenile Hormone Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-juvenile Hormone Agents Scope and Market Size Anti-j…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 飼料固結防止剤の世界市場（～2026年） Market Analysis and Insights: Global Feed Anti-Caking Agents Market The global Feed Anti-Caking Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Feed Anti-Caking Agents Scope and Market Size Feed Anti-Caking Agen…